Navigation Links
Epilepsy Drug Helps Diabetic Nerve Damage

Over the weekend, researchers from Eastern Virginia Medical School presented their study that shows the anti-epileptic drug topiramate improves diabetic neuropathy, or nerve damage.Topiramate (Topamax) has long been used to treat epilepsy, and recent research shows it can also promote significant weight loss. In a small study of people with type 2 diabetes, the drug showed evidence of improving symptoms and markers of neuropathy.// Neuropathy is damage to the nerves that produces pain, impaired heat and pain perception, and disordered skin blood flow that predisposes a person to skin ulcers. Those ulcers can often be cause for amputation.
Aaron Vinik, M.D., from Eastern Virginia Medical School in Norfolk, presented the results of a study in which he and colleagues gave a daily dose of topiramate (no more than 100 milligrams/day) to 11 participants with neuropathy. At the end of the eight-week study, markers of neuropathy -- dendrite length, intraepidermal nerve fiber density and peroneal nerve amplitude -- all increased in the patients. What that means, explains Dr. Vinik, is that the nerves were healing. Patients also experienced increased sensitivity to touch and a significant reduction in pain.

There are other benefits of the drug for type 2 diabetes patients as well, says Dr. Vinik. His study shows the drug reduced triglycerides, decreased hemoglobin A1C levels (a measure of long-term blood sugar control), lowered LDL or "bad" cholesterol, and lowered total cholesterol. Since about 65 percent of people with diabetes will die of heart disease, these are significant benefits for patients.


'"/>




Page: 1

Related medicine news :

1. General Anesthesia Safe For Children On Ketogenic Diet Suffering From Epilepsy
2. Researchers Scale to assess the Severity of Epilepsy in Kids
3. Epilepsy can be predicted
4. Epilepsy Drugs Can Enhance Risk of Birth Defects
5. Epilepsy Drug May Relieve Chronic Headaches
6. More Complications Seen In Women With Epilepsy
7. Epilepsy Drugs Found To Lead To Bone Loss
8. Another Use For Epilepsy Drugs
9. Epilepsy Patients Could Benefit From Pacemakers
10. Early Surgery For Treatment Of Epilepsy Questioned
11. Epilepsy Drug Valproate and Lamotrigine Linked To Malformed Fetus
Post Your Comments:
(Date:10/7/2008)...oduces Color Me Healthy(TM)/Salud Primero to teach...ulum, BENSENVILLE, Ill., Oct. 7 /PRNewswire/ -- L...pansive campaign to bring a comprehensive diet and... Early Head Start,classrooms in an effort to have ...d diabetes in minority children. Lifelink also wil...
(Date:10/7/2008)...w! Everything a Man Wanted to Know But Was Afraid ...e are 4.3 million babies born,in the U.S. each yea...ntil,now. BEING DAD is a revealing, entertaining a... and experiences for dads-to-be from fathers who,h...ry process. It includes,a wealth of advice from se...
(Date:10/7/2008)...aged individuals show signs of awareness, unlike v...lthDay News) -- Severely brain-damaged patients i...n and require painkilling treatment, according to ...state (MCS) is different than a persistent vegetat...t awareness of self or surroundings. MCS patients ...
(Date:10/7/2008)... Oct. 7 /PRNewswire-USNewswire/ -- The Catholic He...conjunction with Catholic,Health Initiatives (CHI)...and Trinity Health, Novi, MI -- is launching a min...climate change., Through receipt of a $20,000 gra... Environment (NRPE) and the Catholic Coalition on,...
Breaking Medicine News(10 mins):Health News:DuPage's Only Provider of Head Start Takes Aim at Childhood Obesity in Minorities 2Health News:DuPage's Only Provider of Head Start Takes Aim at Childhood Obesity in Minorities 3Health News:BEING DAD DVD Offers a Sneak Peek at Pregnancy From a Guy's Point of View 2Health News:Patients in Minimally Conscious State May Still Feel Pain 2Health News:Catholic Health Organizations Launch Ministry-Wide Effort to Raise Awareness About Global Climate Change 2
...r, from the tender age of 4, known widely for his ...ck to his health. No, this was not an accidental f... On Thursday, Mr Diomande collapsed soon after a ...is due to inhalation of anthrax spores. This might...
...mportant position on the National Health Service’s...t month. The obvious reason, clinics in Britain ar...ransmitted diseases. // During a recent survey co... of facilities available, almost one in three doc...
...able-pants' heart failure therapy lack of conclusi...hat too little evidence exists to support a device...eart failure. // The technique in question is cal...a noninvasive therapy to improve blood flow to the...
...Government to distribute subsidized life-saving he... hepatitis C infected patients in Australia. // A...0) currently receive treatment for their condition...earliest, Australia might soon witness a rapid ris...
Other Medicine News:Health News:'Inflatable-pants' heart failure therapy suffers due to lack of evidence. 2
(Date:10/7/2008)...UVER, Oct. 7 / Burcon Nutra...at its Puratein(R) and,Supertein(TM) canola protei... for their intended use in a variety of food and b...affirmed GRAS through an,independent evaluation by...d safety, toxicology, nutritional sciences, food a...
(Date:10/7/2008)...- Data Presented Today at ACG Annual Scientific Me...all/ -- Ironwood,Pharmaceuticals, Inc. (formerly M...: FRX ) today announced the presentation of resul...afety and efficacy in 420 patients with,irritable ... of the data,indicates that once- daily oral dosin...
(Date:10/7/2008)...IEGO, Oct. 7 /- Ardea Biosc... a poster entitled "RDEA119, a Potent,and Highly S... Sulfate,Sodium (DSS) -- induced Chronic Colitis i...Gastroenterology (ACG) 2008 Annual Meeting in Orla... a preclinical study of,RDEA119, the Company,s lea...
(Date:10/6/2008)...ETON, N.J., Oct. 6 /- Pharm...d E.T. Smith, Ph.D., is joining the,Company as Vic...mmunications. Dr. Smith will be responsible for al...ectly to Chief Financial Officer Kurt,Leutzinger.,...d Senior Biotechnology,Analyst at JPMorgan Securit...
Breaking Medicine Technology:Burcon announces GRAS status for Puratein(R) & Supertein(TM) 2Burcon announces GRAS status for Puratein(R) & Supertein(TM) 3Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 2Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 3Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 4Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 5Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 2Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 3Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 4Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications 2Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications 3Wildwood Organics Introduces Probiotic Soymilk 28TM 29 13990 1Wildwood Organics Introduces Probiotic Soymilk 28TM 29 13990 2The Disappearing Toothbrush 3A Survey Reveals Kids Top Excuses to Avoid Brushing 13988 1The Disappearing Toothbrush 3A Survey Reveals Kids Top Excuses to Avoid Brushing 13988 2The Disappearing Toothbrush 3A Survey Reveals Kids Top Excuses to Avoid Brushing 13988 3The Disappearing Toothbrush 3A Survey Reveals Kids Top Excuses to Avoid Brushing 13988 4Open Biosystems Open Access RNAi Program Adopted by Harvard Medical School and University of North Carolina 3848 1Open Biosystems Open Access RNAi Program Adopted by Harvard Medical School and University of North Carolina 3848 2Los Angeles Finest Restaurants Wineries and Chefs Gather in Support of Sexual Health and Rights 13987 1Los Angeles Finest Restaurants Wineries and Chefs Gather in Support of Sexual Health and Rights 13987 2
...oncept in Mice Transgenic for Human TNFa, LAUSANNE...opharm,Group (Debiopharm), a global independent bi...n oncology and serious medical,conditions, announc...lidate the mechanism of action of Debio-0512 as an...ammatory processes in animal,models of acute and c...
...emonstrates Good Safety Profile and Excellent,Phar...N.C., March 13, 2007 /PRNewswire/ --,CeNeRx BioPha...,commercializing innovative treatments for disease...op-line results from a Phase I,clinical trial of T... depression and anxiety. In this study, Tyrima was...
Other Medicine Technology:Preclinical Update - Debio-0512 Therapeutic Vaccine for the,Treatment of Chronic and Acute Inflammatory Conditions 2CeNeRx BioPharma Announces Positive Phase I Results in First Human,Trial of Third Generation RIMA Antidepressant 2CeNeRx BioPharma Announces Positive Phase I Results in First Human,Trial of Third Generation RIMA Antidepressant 3
Dual-sided, Interhemispheric Grid Electrode with 16 Contact Leads; Cortical Grid Electrode with 16 Contact Leads; Pediatric Grid Electrode with Flex Connector, 0.5 cm spacing
.... Gates and Mary E. Dunn at the Minnesota Epilepsy...iability, safety and ease of use. For cortical str...ted flush with the electrode surface, are individu... depth electrodes are fitted with a gold plated mi...
...you with an alternative method for monitoring epil...n as Ad-Techs Spencer Probe Depth Electrodes, exce...e instead of a stylet. Features include a smaller ... contacts, 5.0 mm standard contact spacing, and de...
...r controlled tissue modification in small joint ap...leable tip, controlled capsuloligamentous or tendi...ieved. When used in conjunction with the OPES Elec...eal time tissue impedance tracking allows the,OP...
Medicine Products: